{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:44:28Z","timestamp":1792014268225,"version":"4.4.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1,12]]},"abstract":"<jats:p>Unusual blood clots can cause serious health problems, such as lung embolism, stroke, and heart attack. Inhibiting thrombin activity was adopted as an effective strategy for preventing blood clots. In this study, we explored computational-based method for designing peptide inhibitors of human thrombin therapeutic peptides to prevent platelet aggregation. The random peptides and their 3-dimentional structures were generated to build a virtual peptide library. The generated peptides were docked into the binding pocket of human thrombin. The designed strong binding peptides were aligned with the native binder by comparative study, and we showed the top 5 peptide binders display strong binding affinity against human thrombin. The 5 peptides were synthesized and validated their inhibitory activity. Our result showed the 5-mer peptide AEGYA, EVVNQ, and FASRW with inhibitory activity against thrombin, range from 0.53 to 4.35 \u03bcM. In vitro anti-platelet aggregation assay was carried out, suggesting the 3 peptides can inhibit the platelet aggregation induced by thrombin. This study showed computer-aided peptide inhibitor design can be a robust method for finding potential binders for thrombin, which provided solutions for anticoagulation.<\/jats:p>","DOI":"10.1097\/md.0000000000036849","type":"journal-article","created":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T15:02:58Z","timestamp":1705071778000},"page":"e36849","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Discovering peptide inhibitors of thrombin as a strategy for anticoagulation"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-7543-540X","authenticated-orcid":false,"given":"Shuxin","family":"Zhen","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Tangshan Gongren Hospital, Tangshan, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiping","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tangshan Gongren Hospital, Tangshan, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Li","sequence":"additional","affiliation":[{"name":"Department of General Practice, Tangshan Gongren Hospital, Tangshan, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tangshan Gongren Hospital, Tangshan, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tangshan Gongren Hospital, Tangshan, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Visual Communication Design, Gengdan Institute of Beijing University of Technology, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.tibtech.2021.11.003","article-title":"Bioengineering artificial blood vessels from natural materials.","volume":"40","author":"Moore","year":"2022","journal-title":"Trends Biotechnol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijcard.2023.05.051","article-title":"Effect of prior anticoagulation therapy on stroke severity and in-hospital outcomes in patients with acute ischemic stroke and atrial fibrillation.","volume":"15","author":"Zhou","year":"2023","journal-title":"Int J Cardiol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"717835","DOI":"10.3389\/fcvm.2021.717835","article-title":"Effects of heparin and bivalirudin on thrombin-induced platelet activation: differential modulation of PAR signaling drives divergent prothrombotic responses.","volume":"8","author":"Lund","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-3-642-23056-1_3","article-title":"The anticoagulant and antithrombotic mechanisms of heparin.","volume":"207","author":"Gray","year":"2012","journal-title":"Handb Exp Pharmacol"},{"key":"R5-20250504","first-page":"408","article-title":"Bivalirudin as an alternative to heparin for anticoagulation in infants and children.","volume":"20","author":"Buck","year":"2015","journal-title":"J Pediatr Pharmacol Ther"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41573-020-00135-8","article-title":"Trends in peptide drug discovery.","volume":"20","author":"Muttenthaler","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","article-title":"Therapeutic peptides: current applications and future directions.","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1007\/s10989-019-10012-7","article-title":"computational peptide engineering approach for selection the best engendered camel lactoferrin-derive peptide with potency to interact with DNA.","volume":"26","author":"Pirkhezranian","year":"2020","journal-title":"Int J Pept Res Ther"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12864-020-6458-7","article-title":"Interaction of camel Lactoferrin derived peptides with DNA: a molecular dynamics study.","volume":"21","author":"Pirkhezranian","year":"2020","journal-title":"BMC Genomics"},{"key":"R10-20250504","article-title":"Possibilities of Using De Novo Design for Generating Diverse Functional Food Enzymes.","volume":"24","author":"Wang","year":"2023","journal-title":"Int J Mol Sci [serial on the Internet]"},{"key":"R11-20250504","first-page":"75","article-title":"AI-assisted food enzymes design and engineering: a critical review.","volume":"3","author":"Wang","year":"2023","journal-title":"SMAB"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"2250029","DOI":"10.1142\/S0219720022500299","article-title":"In silico de novo drug design of a therapeutic peptide inhibitor against UBE2C in breast cancer.","volume":"21","author":"Anonuevo","year":"2022","journal-title":"J Bioinform Comput Biol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.4155\/fmc.10.259","article-title":"Design and development of peptides and peptide mimetics as antagonists for therapeutic intervention.","volume":"2","author":"Mason","year":"2010","journal-title":"Future Med Chem"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.addr.2020.11.007","article-title":"Peptide and peptide-based inhibitors of SARS-CoV-2 entry.","volume":"167","author":"Sch\u00fctz","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"114681","DOI":"10.1016\/j.ejmech.2022.114681","article-title":"(1R,3S)-THCCA-Asn: To show the discovery of selective inhibitor of thrombin by successfully combining virtual screening and biological assay.","volume":"242","author":"Zhang","year":"2022","journal-title":"Eur J Med Chem"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/08905436.2022.2052311","article-title":"Isolation and identification of thrombin-inhibiting peptides derived from soybean protein.","volume":"36","author":"Xu","year":"2022","journal-title":"Food Biotechnol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"105640","DOI":"10.1016\/j.compbiomed.2022.105640","article-title":"Simple method for assessment of activities of thrombin inhibitors through their molecular structure parameters.","volume":"146","author":"Keshavarz","year":"2022","journal-title":"Comput Biol Med"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1002\/prot.22716","article-title":"Sub-angstrom modeling of complexes between flexible peptides and globular proteins.","volume":"78","author":"Raveh","year":"2010","journal-title":"Proteins"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"e1005905","DOI":"10.1371\/journal.pcbi.1005905","article-title":"High-resolution global peptide-protein docking using fragments-based PIPER-FlexPepDock.","volume":"13","author":"Alam","year":"2017","journal-title":"PLoS Comput Biol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"C1149","DOI":"10.1111\/j.1750-3841.2011.02367.x","article-title":"Characterization of ACE-inhibitory peptide associated with antioxidant and anticoagulation properties.","volume":"76","author":"Yu","year":"2011","journal-title":"J Food Sci"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00217-017-2946-7","article-title":"Thrombin inhibitory peptides derived from Mytilus edulis proteins: identification, molecular docking and in silico prediction of toxicity.","volume":"244","author":"Feng","year":"2018","journal-title":"Eur Food Res Technol"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"e20161","DOI":"10.1371\/journal.pone.0020161","article-title":"RosettaScripts: a scripting language interface to the rosetta macromolecular modeling suite.","volume":"6","author":"Fleishman","year":"2011","journal-title":"PLoS One"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1021\/jm0109513","article-title":"Structure-based design of novel potent nonpeptide thrombin inhibitors.","volume":"45","author":"Hauel","year":"2002","journal-title":"J Med Chem"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"e59004","DOI":"10.1371\/journal.pone.0059004","article-title":"A Pareto-optimal refinement method for protein design scaffolds.","volume":"8","author":"Niv\u00f3n","year":"2013","journal-title":"PLoS One"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"15268","DOI":"10.1021\/acs.jafc.1c05256","article-title":"Significantly improving the thermostability and catalytic efficiency of streptomyces mobaraenesis transglutaminase through combined rational design.","volume":"69","author":"Wang","year":"2021","journal-title":"J Agric Food Chem"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"e0140359","DOI":"10.1371\/journal.pone.0140359","article-title":"Enhancements to the rosetta energy function enable improved identification of small molecules that inhibit protein-protein interactions.","volume":"10","author":"Bazzoli","year":"2015","journal-title":"PLoS One"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"6201","DOI":"10.1021\/acs.jctc.6b00819","article-title":"Simultaneous optimization of biomolecular energy functions on features from small molecules and macromolecules.","volume":"12","author":"Park","year":"2016","journal-title":"J Chem Theory Comput"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers.","volume":"1-2","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","article-title":"gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS.","volume":"17","author":"Vald\u00e9s-Tresanco","year":"2021","journal-title":"J Chem Theory Comput"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/psc.3052","article-title":"Structural and functional studies of differentially O-glycosylated analogs of a thrombin inhibitory peptide \u2013 variegin.","volume":"23","author":"Shabareesh","year":"2017","journal-title":"J Pept Sci"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"e45012","DOI":"10.1371\/journal.pone.0045012","article-title":"Towards the improved discovery and design of functional peptides: common features of diverse classes permit generalized prediction of bioactivity.","volume":"7","author":"Mooney","year":"2012","journal-title":"PLoS One"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3390\/molecules26020430","article-title":"A global review on short peptides: frontiers and perspectives.","volume":"26","author":"Apostolopoulos","year":"2021","journal-title":"Molecules"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"175192","DOI":"10.1016\/j.ejphar.2022.175192","article-title":"In vivo degradation forms, anti-degradation strategies, and clinical applications of therapeutic peptides in non-infectious chronic diseases.","volume":"932","author":"Tasdemiroglu","year":"2022","journal-title":"Eur J Pharmacol"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"590","DOI":"10.2174\/157018005774717343","article-title":"Discovery of thrombin inhibitor fragments from chemical microarray screening.","volume":"2","author":"Neumann","year":"2005","journal-title":"Lett Drug Des Discovery"},{"key":"R35-20250504","article-title":"Computer-aided designing peptide inhibitors of human hematopoietic prostaglandin D2 synthase combined molecular docking and molecular dynamics simulation.","volume":"28","author":"Cui","year":"2023","journal-title":"Molecules [serial on the Internet]"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"132704","DOI":"10.1016\/j.molstruc.2022.132704","article-title":"Identification of potential inhibitors for Hematopoietic Prostaglandin D2 synthase: computational modeling and molecular dynamics simulations.","volume":"1259","author":"Beura","year":"2022","journal-title":"J Mol Struct"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/0968-0896(95)00107-R","article-title":"New tripeptidic thrombin inhibitors Influence of P2 and P3 residues on activity and selectivity.","volume":"38","author":"de Nanteuil","year":"1995","journal-title":"Bioorg Med Chem"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"8554","DOI":"10.3390\/ijms23158554","article-title":"The screening of therapeutic peptides for anti-inflammation through phage display technology.","volume":"23","author":"Zhang","year":"2022","journal-title":"Int J Mol Sci"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000036849","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T23:14:35Z","timestamp":1746314075000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000036849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,12]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000036849","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,12]]}}}